Business
Regulation of Peptides Sparks Debate
An FDA advisory panel recently voted to approve some popular peptides, drawing attention to the unregulated market for these products. The decision has raised concerns about safety and regulation.
Coverage timeline — 1 article
NPR
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.
2026-08-03 11:00 UTC